Lou L. M.
- Country
- France
- Department
- Hopital Robert Debre - Centre Hospitalo Universitaire (CHU) Service Hematologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 12 partner sites.
Specializations
Hematologic Malignancies
The investigator leads studies on Acute Myeloid Leukemia across risk strata. Research also encompasses Acute Lymphoblastic Leukemia in adult cohorts. Additional focus includes Multiple Myeloma and its refractory forms.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Multiple Myeloma
- Diffuse Large B‑Cell Lymphoma
- Myelodysplastic Syndromes
These programs aim to improve survival outcomes and disease control in high‑risk blood cancers.
Stem Cell and Cellular Therapies
Clinical work includes allogeneic Hematopoietic Stem Cell Transplantation for malignant and non‑malignant disorders. The team evaluates haploidentical donor strategies and post‑transplant immune reconstitution.
- Allogeneic HSCT
- Haploidentical transplantation
- Cellular immunotherapy
- Post‑transplant infection prophylaxis
- Graft‑versus‑host disease management
Efforts target reduced transplant‑related morbidity and enhanced graft efficacy.
Rare Hematologic and Genetic Disorders
Investigations cover inherited protein‑misfolding diseases such as Hereditary Transthyretin Amyloidosis. The group also studies coagulation deficiencies including Hemophilia A and severe von Willebrand disease.
- Hereditary Transthyretin Amyloidosis
- Hemophilia A
- Von Willebrand Disease
- Alpha‑1 Antitrypsin Deficiency‑related liver disease
- Hereditary Angioedema
These studies aim to define disease mechanisms and evaluate novel therapeutic options.
Coagulation, Thrombosis and Bleeding
Projects address venous and arterial clotting disorders, notably Venous Thromboembolism in cancer patients. The team also investigates bleeding risk in anticoagulated populations.
- Venous Thromboembolism
- Anticoagulation safety
- Platelet dysfunction
- Thrombotic microangiopathy
- Bleeding management in hematologic disease
Outcomes focus on balancing thrombosis prevention with hemorrhagic safety.
Autoimmune Hematology
The program evaluates immune‑mediated cytopenias such as Immune Thrombocytopenia. It also explores systemic autoimmune conditions with hematologic impact, including Systemic Lupus Erythematosus‑associated nephritis.
- Immune Thrombocytopenia
- Autoimmune Hemolytic Anemia
- Lupus Nephritis
- Antiphospholipid syndrome
- ANCA‑associated vasculitis
Research seeks targeted immunomodulation to restore normal hematopoiesis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.